Hantavirus pulmonary syndrome
Hantavirus pulmonary syndrome clinical and global spread profile: 3 countries, 4 WHO outbreak events since 2000.
Hantavirus pulmonary syndrome · ICD-10 B334 · ICD-11 1D62 · 4 WHO events across 3 countries (2000–2019).
Top affected countries
| Country | Region | Events | % of global |
|---|---|---|---|
| Panama | AMR | 2 | 50% |
| Argentina | AMR | 1 | 25% |
| United States of America | AMR | 1 | 25% |
Annual outbreak timeline
| Year | Events | Countries |
|---|---|---|
| 2019 | 2 | 2 |
| 2012 | 1 | 1 |
| 2000 | 1 | 1 |
Peak year: 2019 (2 events).
Decade summary
| Decade | Events |
|---|---|
| 2000s | 1 |
| 2010s | 3 |
WHO case definition
An acute zoonotic viral disease characterised by abrupt onset of fever, influenza-like clinical signs (e.g., chills, headache, myalgia, dry cough), gastrointestinal signs (e.g., diffuse abdominal pain, vomiting, diarrhoea), transient troubled vision (acute myopia), lumbalgia due to renal swelling, haemorrhagic manifestations to various degrees sometimes followed by rapidly increasing dyspnoea due to not-cardiogenic acute lung oedema, and/or renal involvement. The latter is characterised by initial, often massive proteinuria and microhaematuria sometimes accompanied by transient renal function impediment. All hantavirus infections are heralded by varying degrees of transient thrombocytopenia, which may serve as an indicator of clinical severity.
Countries Affected
3
Outbreak Events
4
Year Range
2000–2019
ICD-10 B334
Hantavirus pulmonary syndrome
Visualization
Global Prevalence Snapshot
Based on WHO Disease Outbreak News events (2000–2019).
Risk Level
Continue exploring
